Connection
Ronda Henry-Tillman to Carcinoma, Lobular
This is a "connection" page, showing publications Ronda Henry-Tillman has written about Carcinoma, Lobular.
|
|
Connection Strength |
|
 |
|
 |
|
0.375 |
|
|
|
-
Kepple J, Layeeque R, Klimberg VS, Harms S, Siegel E, Korourian S, Gusmano F, Henry-Tillman RS. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg. 2005 Oct; 190(4):623-7.
Score: 0.254
-
Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC, Hutchins LF. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 2015 Feb; 38(1):74-9.
Score: 0.121